van Mens Suzan P, Meijvis Sabine C A, Grutters Jan C, Vlaminckx Bart J M, Bos Willem J W, Rijkers Ger T
Department of Medical Microbiology & Immunology, St. Antonius Hospital, Nieuwegein, the Netherlands.
Clin Vaccine Immunol. 2012 May;19(5):811-3. doi: 10.1128/CVI.05697-11. Epub 2012 Feb 29.
In this study, the effect of dexamethasone on the formation of pneumococcal antibodies during community-acquired pneumonia (CAP) was investigated. No differences between CAP patients receiving dexamethasone as additional therapy and patients receiving a placebo were found with respect to immune response rates and mean baseline and convalescent-phase antibody concentrations.
在本研究中,调查了地塞米松对社区获得性肺炎(CAP)期间肺炎球菌抗体形成的影响。在免疫反应率以及平均基线和恢复期抗体浓度方面,接受地塞米松作为附加治疗的CAP患者与接受安慰剂的患者之间未发现差异。